Recent Updates
Recently added Catalysts
NBIX

Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D. Neurocrine Biosciences, Inc. (Nasdaq: NBIX) is sad to announce that its academic founder and member of the Board of Directors, Wylie W. Vale, Ph.D....

Key Takeaway: SAN DIEGO , Jan. 7, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) is sad to announce that its academic founder and member of the Board of Directors, Wylie W. Vale , Ph.D. passed away earlier this week. He was a thoughtful leader with an incredible scientific m

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+37%
120-day peak, hindsight
Typical move
3.5%
average across 4 past catalysts
Lead asset
NBI-6024
Phase 1 · Type 1 Diabetes Mellitus

Full Press Release Details

SAN DIEGO , Jan. 7, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) is sad to announce that its academic founder and member of the Board of Directors, Wylie W. Vale , Ph.D. passed away earlier this week. He was a thoughtful leader with an incredible scientific mind who will be sorely missed. "Wylie's intellect was matched by his terrific wit and disarming good nature. He was a good friend," said Kevin Gorman , President and Chief Executive Officer of Neurocrine. The entire Neurocrine team mourns his passing and extends its sympathies to the Vale family.
SOURCE Neurocrine Biosciences, Inc.

21 %

Last updated: Jan 7, 2012